VC-Backed Gossamer Bio Begins Trading After $276M IPO
San Diego-based biopharmaceutical company Gossamer Bio started trading on the Nasdaq Global Select Market on Friday after the Latham & Watkins LLP-led company priced a $276 million initial public offering....To view the full article, register now.
Already a subscriber? Click here to view full article